Amylase Isoenzymes

The Amylase Isoenzymes test separates or individually measures the main forms of amylase circulating in the blood. Amylase is a digestive enzyme that breaks down starch and other carbohydrates. It is produced mainly by the pancreas and salivary glands. A routine total amylase test measures the combined enzyme activity but does not always show which tissue is responsible for an elevated result.

Amylase isoenzyme analysis helps distinguish pancreatic-type amylase from salivary-type amylase. This additional information may be useful when total amylase remains elevated, when symptoms do not clearly indicate a pancreatic cause or when the doctor needs to investigate a non-pancreatic source. The test is interpreted with symptoms, lipase, imaging and other laboratory findings.

Benefits of the Test

• Differentiates pancreatic and salivary amylase fractions.
• Helps identify the likely source of an elevated total amylase result.
• Supports evaluation of pancreatic and salivary-gland conditions.
• May assist in investigating persistent unexplained hyperamylasemia.
• Can provide clues during assessment for macroamylasemia.
• Helps doctors decide whether additional pancreatic or non-pancreatic testing is needed.

Why Doctors Recommend This Test

A doctor may recommend amylase isoenzyme testing when total serum amylase is repeatedly or unexpectedly elevated. Pancreatic-type amylase may rise with acute pancreatitis, pancreatic-duct obstruction, pancreatic trauma, pseudocyst, pancreatic surgery or selected other abdominal conditions. However, lipase is generally more specific for acute pancreatitis and is commonly interpreted with amylase rather than replaced by isoenzyme testing.

Salivary-type amylase may increase with salivary-gland inflammation or obstruction, including conditions such as parotitis. It may also rise with vomiting, selected tumours, some gynaecological conditions and other non-pancreatic illnesses. An isoenzyme pattern can help direct the investigation, but it cannot independently identify the exact disease.

The test may also be considered when a patient has persistently high serum amylase without symptoms or imaging evidence of pancreatic disease. One possible explanation is macroamylasemia, a usually benign condition in which amylase binds to an immunoglobulin or another large molecule. The resulting complex remains in the blood because it is not readily filtered by the kidneys. Additional serum and urine testing may be required to evaluate this possibility.

Preparation Before Test

Fasting may be requested depending on the laboratory protocol and other tests ordered at the same time. Follow the collection instructions provided by the doctor or laboratory. Tell the healthcare team about abdominal or salivary-gland symptoms, kidney or liver disease, recent procedures, alcohol intake and all medicines or supplements.

Some medicines and clinical conditions may influence amylase levels. Do not stop prescribed treatment unless instructed by the treating doctor. A venous blood sample is generally used. The doctor may request simultaneous total amylase, lipase, kidney-function tests or a urine amylase measurement to improve interpretation.

Normal Reporting Time

Amylase isoenzyme analysis is a specialized test and generally requires several working days. The exact turnaround time depends on the analytical method, testing schedule, specimen transportation, sample quality and whether repeat or confirmatory analysis is necessary. Focus Diagnostics will provide the applicable reporting estimate during sample collection.

Who Should Take This Test?

• Patients with persistent or unexplained elevation of total amylase.
• People whose amylase result does not match their symptoms or imaging findings.
• Patients being assessed for a pancreatic versus salivary source of amylase.
• Individuals with suspected salivary-gland inflammation or obstruction.
• Patients being investigated for possible macroamylasemia.
• People requiring follow-up of selected pancreatic or abdominal conditions.
• Anyone specifically advised to undergo testing by a gastroenterologist or physician.

Detailed Information

The two principal groups are pancreatic-type amylase and salivary-type amylase. The laboratory may measure these using an inhibition method, electrophoretic separation or another validated technique. Results may be reported as concentrations, activities, percentages or individual fractions. The reference intervals depend on the method used.

An increased pancreatic fraction can support a pancreatic source but does not establish acute pancreatitis by itself. Symptoms, lipase, liver tests, inflammatory markers and ultrasound, CT, MRI or other imaging may be needed. Amylase can return toward normal even while a pancreatic problem remains, and the magnitude of elevation does not consistently reflect disease severity.

A predominantly salivary pattern directs attention toward salivary glands and other non-pancreatic sources. Depending on the symptoms, additional evaluation may include physical examination, salivary-gland imaging, infection testing or assessment for other systemic conditions.

Kidney impairment can increase serum amylase because clearance is reduced. Macroamylasemia may cause high serum amylase with relatively low urinary amylase. Doctors may calculate an amylase-to-creatinine clearance ratio or request other laboratory studies, but these findings require clinical interpretation.

A result within the stated reference interval does not exclude every pancreatic or salivary condition. Likewise, an abnormal isoenzyme fraction does not establish cancer or another specific diagnosis. The final assessment should be made by the treating doctor after reviewing the complete clinical and laboratory picture.